Elevation in Plasma Abeta42 in Geriatric Depression: A Pilot Study

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurochemical Research

• Publication date

  2006-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s11064-005-9029-zPMID 16583267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.

  2005cited by this paper
• [O1‐03‐08]: Amyloid imaging with Pittsburgh Compound‐B in late‐life depression

  2005cited by this paper
• [S1‐01‐01]: Amyloid imaging with Pittsburgh Compound B

  2005cited by this paper
• Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.

  2005cited by this paper
• Selective reductions in plasma Abeta 1-42 in healthy elderly subjects during longitudinal follow-up: a preliminary report.

  2005cited by this paper
• Apolipoprotein E ε4 Allele and Lorazepam Effects on Memory in High-Functioning Older Adults.

  2005cited by this paper
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

  2004cited by this paper
• Neuropathologic Correlates of Late-Onset Major Depression

  2004cited by this paper
• The nature and determinants of neuropsychological functioning in late-life depression.

  2004cited by this paper
• Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

  2004cited by this paper
• Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.

  2004cited by this paper
• Clearance of Alzheimer's Aβ Peptide

  2004cited by this paper
• Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.

  2004cited by this paper
• Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

  2004cited by this paper
• Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.

  2004cited by this paper
• Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau

  2004cited by this paper
• Amyloid Angiopathy–Related Vascular Cognitive Impairment

  2004cited by this paper
• Spectroscopic characterization of Phaseolus vulgaris leucoagglutinin.

  2004cited by this paper
• β-Amyloid (1–42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex

  2004cited by this paper
• Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions

  2004cited by this paper
• Biophysical changes in normal-appearing white matter and subcortical nuclei in late-life major depression detected using magnetization transfer.

  2004cited by this paper
• Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression.

  2004cited by this paper
• Unaltered plasma levels of beta-amyloid(1-40) and beta-amyloid(1-42) upon stimulation of human platelets.

  2003cited by this paper
• Unaltered Plasma Levels of β-Amyloid(1–40) and β-Amyloid(1–42) upon Stimulation of Human Platelets

  2003cited by this paper
• Plasma A&bgr;40 and A&bgr;42 and Alzheimer’s disease: Relation to age, mortality, and risk

  2003cited by this paper
• Detection of amyloid plaques by radioligands for Aβ40 and Aβ42

  2003cited by this paper
• Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.

  2003cited by this paper
• Role of executive function in late-life depression.

  2003cited by this paper
• Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk.

  2003cited by this paper
• Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study.

  2002cited by this paper
• Depressive symptoms, cognitive decline, and risk of AD in older persons

  2002cited by this paper
• Depressive symptoms and cognitive decline in elderly people. Longitudinal study.

  2002cited by this paper
• History of Depression as a Risk Factor for Dementia: An Updated Review

  2001cited by this paper
• Elevated plasma amyloid β-peptide 1–42 and onset of dementia in adults with Down syndrome

  2001cited by this paper
• Elevated P-selectin on platelets in depression: response to bupropion.

  2000cited by this paper
• Platelet activation in depression and effects of sertraline treatment: An open-label study.

  2000cited by this paper
• Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.

  2000cited by this paper
• Plasma amyloid β‐peptide 1–42 and incipient Alzheimer's disease

  1999cited by this paper
• Prefrontal dysfunction and treatment response in geriatric depression.

  1999cited by this paper
• Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease.

  1999cited by this paper
• Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study.

  1999cited by this paper
• A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.

  1999cited by this paper
• Increased plasma amyloid β protein 1–42 levels in Down syndrome

  1998cited by this paper
• Increased plasma amyloid beta protein 1-42 levels in Down syndrome.

  1998cited by this paper
• Cerebrospinal Fluid Levels of Amyloid Precursor Protein and Amyloid β-Peptide in Alzheimer’s Disease and Major Depression – Inverse Correlation with Dementia Severity

  1998cited by this paper
• Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.

  1997cited by this paper
• 'Vascular depression' hypothesis.

  1997cited by this paper
• Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Exaggerated platelet reactivity in major depression.

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

  1996cited by this paper
• Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

  1996cited by this paper
• Platelets are the primary source of amyloid beta-peptide in human blood.

  1995cited by this paper
• Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood

  1995cited by this paper
• Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet.

  1994cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Magnetic Resonance Spectroscopy Insights Into Late‐Life Depression: Advances in Brain Metabolic Profiling

  2025cites this paper
• Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease

  2024cites this paper
• Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline

  2024cites this paper
• Clinical course and serum amyloid β levels in elderly patients with major depressive disorder.

  2022cites this paper
• Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer's disease?

  2021cites this paper
• Plasma amyloid ϐ 40/42 ratio and its characteristics

  2021cites this paper
• Different Sides of Depression in the Elderly: An In-depth View on the Role of Aβ Peptides.

  2021cites this paper
• Is there a relationship between morphological and functional platelet changes and depressive disorder?

  2020cites this paper
• Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer's Disease Neuroimaging Initiative Depression Project.

  2020cites this paper
• Plasma levels of Interleukin 18 but not amyloid-β or Tau are elevated in female depressive patients.

  2020cites this paper
• Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses.

  2020cites this paper
• Serum levels and mutual correlations of amyloid β in patients with depression

  2019cites this paper
• Dot-blot sandwich immunoassay with silver signal enhancement for simple amyloid beta protein fragment 1-42 detection

  2019cites this paper
• Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task

  2019cites this paper
• Glucocorticoid may influence amyloid β metabolism in patients with depression.

  2018cites this paper
• Effects of n‐3 PUFA enriched and n‐3 PUFA deficient diets in naïve and A&bgr;‐treated female rats

  2018cites this paper
• Emerging role of amyloid beta in stress response: Implication for depression and diabetes.

  2017cites this paper
• The characteristic of cognitive dysfunction in remitted late life depression and amnestic mild cognitive impairment.

  2017cites this paper
• SB203580 reverses memory deficits and depression-like behavior induced by microinjection of Aβ1–42 into hippocampus of mice

  2017cites this paper
• Antidepressant drugs for beta amyloid‐induced depression: A new standpoint?

  2017cites this paper
• Electrochemical immunoassay for amyloid-beta 1–42 peptide in biological fluids interfacing with a gold nanoparticle modified carbon surface

  2017cites this paper
• Amyloid‐associated depression and ApoE4 allele: longitudinal follow‐up for the development of Alzheimer's disease

  2016cites this paper
• Serum Levels of Albumin-β-Amyloid Complex in Patients with Depression.

  2016cites this paper
• Association of Cerebral Amyloidosis, Blood Pressure, and Neuronal Injury with Late-Life Onset Depression

  2016cites this paper
• Effects of Heart Bypass Surgery on Plasma Aβ40 and Aβ42 Levels in Infants and Young Children

  2016cites this paper
• State-dependent alterations in cerebrospinal fluid A&bgr;42 levels in cognitively intact elderly with late-life major depression

  2016cites this paper
• Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?

  2016cites this paper
• Major Depression May Lead to Elevations in Potentially Neurotoxic Amyloid Beta Species Independently of Alzheimer Disease.

  2016cites this paper
• The Amyloid Hypothesis: Is There a Role for Anti-amyloid Treatment in Late-Life Depression?

  2016cites this paper
• Dépression de la personne âgée : Comparaison des troubles à début précoce et des troubles à début tardif : étude rétrospective

  2015cites this paper
• Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis.

  2015cites this paper
• Amyloid-beta and depression in healthy older adults: A systematic review

  2015cites this paper
• Soluble amyloid-β levels and late-life depression.

  2014cites this paper
• A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan

  2014cites this paper
• Is there a role for β-amyloid in depression?

  2014cites this paper
• A systematic review of amyloid-β peptides as putative mediators of the association between affective disorders and Alzheimer׳s disease.

  2014cites this paper
• Psychological well-being and regional brain amyloid and tau in mild cognitive impairment.

  2014cites this paper
• Current Understanding of the Neurobiology and Longitudinal Course of Geriatric Depression

  2014cites this paper
• Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease.

  2014cites this paper
• Plasma Amyloid-β Levels in Drug-Resistant Bipolar Depressed Patients Receiving Electroconvulsive Therapy

  2013cites this paper
• Heterogeneity of elderly depression: increased risk of Alzheimer's disease and Aβ protein metabolism.

  2013cites this paper
• Neurodegeneration, β‐amyloid and mood disorders: state of the art and future perspectives

  2013cites this paper
• Plasma amyloid β, depression, and dementia in community-dwelling elderly.

  2013cites this paper
• Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.

  2012cites this paper
• Variability in Blood-Based Amyloid-β Assays: The Need for Consensus on Pre-Analytical Processing

  2012cites this paper
• Metabolism of amyloid-β protein may be affected in depression.

  2012cites this paper
• Correlating Neuropsychiatric Symptoms with Regional Beta-Amyloid Load in the Alzheimer’s Disease Brain Using [11C]SB-13 Positron Emission Tomography

  2011cites this paper
• Protein binding in patients with late-life depression.

  2011cites this paper
• The correlation of plasma Aβ42 levels, depressive symptoms, and cognitive function in the Korean elderly.

  2011cites this paper
• Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease

  2010cites this paper
• Brain neurotoxic amyloid‐beta peptides: their potential role in the pathophysiology of depression and as molecular therapeutic targets

  2010cites this paper
• Plasma Amyloid-β Forms in Alzheimer's Disease and Non-Alzheimer's Disease Patients

  2010cites this paper
• Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease.

  2010cites this paper
• Soluble βamyloid1‐42: a critical player in producing behavioural and biochemical changes evoking depressive‐related state?

  2010cites this paper
• Troponin and S100β are associated with depression in healthy older adults

  2009cites this paper
• Serum amyloid β protein in young and elderly depression: a pilot study

  2009cites this paper
• [Biomarkers for early diagnosis of Alzheimer's disease: current update and future directions].

  2009cites this paper
• Does Alzheimer's Disease Result from Attempts at Repair or Protection After Transient Stress?

  2009cites this paper
• Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.

  2009cites this paper
• Amyloid-associated depression: a prodromal depression of Alzheimer disease?

  2008cites this paper
• Investigation of brain beta amyloid deposition and plasma beta amyloid level in late life onset depression

  2008cites this paper
• Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?

  2008cites this paper
• Depression is associated with low plasma Aβ42 independently of cardiovascular disease in the homebound elderly

  2007cites this paper
• Depression, Antidepressants, and Plasma Amyloid β (Beta) Peptides in Those Elderly Who Do Not Have Cardiovascular Disease

  2007cites this paper
• Possible therapeutic implication of Aβ disturbances in depression

  2007cites this paper
• Depression, antidepressants, and plasma amyloid beta (Beta) peptides in those elderly who do not have cardiovascular disease.

  2007cites this paper
• Plasma Aβ42 levels and depression in the elderly

  2007cites this paper
• New Possibilites for Early Diagnosis of Alzheimer Disease: "Alzheimer Associated Gene" and Blood Biomarkers Nowe możliwości sprzyjające wczesnemu rozpoznawaniu choroby Alzheimera: "Alzheimer Associated Gene" i biomarkery krwi

  2007cites this paper
• Humoral immune responses to peptides derived from the β-amyloid peptide C-terminal sequence

  2007cites this paper
• Blood‐based neurochemical diagnosis of vascular dementia: a pilot study

  2007cites this paper
• Aβ42 is More Rigid than Aβ40 at the C Terminus: Implications for Aβ Aggregation and Toxicity

  2006cites this paper
• Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.

  2006cites this paper